Overview of Bioactive Fungal Secondary Metabolites: Cytotoxic and Antimicrobial Compounds
Related Experiment Video
Updated: Aug 20, 2025

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
Published on: December 5, 2020
Rafael Conrado1, Tainah Colombo Gomes1, Gabriella Sales Calaço Roque1
1Development and Innovation Laboratory, Instituto Butantan, Avenida Vital Brasil, 1500, São Paulo 05503-900, SP, Brazil.
Abstract:
Microorganisms are known as important sources of natural compounds that have been studied and applied for different purposes in distinct areas. Specifically, in the pharmaceutical area, fungi have been explored mainly as sources of antibiotics, antiviral, anti-inflammatory, enzyme inhibitors, hypercholesteremic, antineoplastic/antitumor, immunomodulators, and immunosuppressants agents. However, historically, the high demand for new antimicrobial and antitumor agents has not been sufficiently attended by the drug discovery process, highlighting the relevance of intensifying studies to reach sustainable employment of the huge world biodiversity, including the microorganisms. Therefore, this review describes the main approaches and tools applied in the search for bioactive secondary metabolites, as well as presents several examples of compounds produced by different fungi species with proven pharmacological effects and additional examples of fungal cytotoxic and antimicrobial molecules. The review does not cover all fungal secondary metabolites already described; however, it presents some reports that can be useful at any phase of the drug discovery process, mainly for pharmaceutical applications.
Related Concept Videos
Overview of Fungi
Fungal Phylum Basidiomycota
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Biological Methods for Microbial Control
Antimicrobial Effectiveness
Fungal Phylum Ascomycota

